About Aeris Therapeutics
Aeris Therapeutics is a company based in Woburn (United States) founded in 2000 was acquired by Pulmonx in January 2015. Aeris Therapeutics operates in a competitive market with competitors including Pulmonx, Neurent Medical, Gradient Denervation Technologies, Spiration and Uptake Medical, among others.
- Headquarter Woburn, United States
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Aeris Therapeutics
Investors in Aeris Therapeutics
Aeris Therapeutics has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include Pulmonx and HHS.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Public health and human services are overseen by HHS.
|
Locked | Locked | Locked | |
|
Developer of smart devices for treating pulmonary diseases
|
Locked | Locked | Locked |
Investor details for Aeris Therapeutics
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Aeris Therapeutics
Investment portfolio details for Aeris Therapeutics
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Aeris Therapeutics
Detailed financials for Aeris Therapeutics
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Aeris Therapeutics Comparisons
Peer comparison for Aeris Therapeutics
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Aeris Therapeutics
Aeris Therapeutics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Pulmonx, Neurent Medical, Gradient Denervation Technologies, Spiration and Uptake Medical, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Developer of smart devices for treating pulmonary diseases
|
|
| Locked | Locked | Locked |
Smart devices for minimally invasive rhinitis treatment are developed.
|
|
| Locked | Locked | Locked |
Endovascular catheter-based technology for pulmonary hypertension treatment is provided.
|
|
| Locked | Locked | Locked |
IntraBronchial Valve to treat lung disease
|
|
| Locked | Locked | Locked |
Targeted vapor therapy is developed for endoscopic lung volume reduction.
|
|
| Locked | Locked | Locked |
Endobronchial valves for emphysema treatment are developed.
|
Detailed competitors of Aeris Therapeutics
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Aeris Therapeutics
Complete news archive for Aeris Therapeutics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Aeris Therapeutics
Aeris Therapeutics was founded in 2000 and raised its 1st funding round 4 years after it was founded.
Aeris Therapeutics is headquartered in Woburn, United States. It is registered at Woburn, Massachusetts, United States.
Aeris Therapeutics was founded in 2000 and is based in Woburn, United States. Focus is placed on medical devices within the pulmonology sector. The AeriSeal System is provided to decrease lung volume and enhance function for individuals with severe emphysema. Damaged lung regions are addressed through bronchoscope-based procedures. Operations center on advancing treatments for emphysema and related respiratory conditions.
Aeris Therapeutics's top competitors include Pulmonx, Neurent Medical and Gradient Denervation Technologies.